Plantlibra

From Opasnet
Revision as of 07:48, 15 January 2014 by Lhiq (talk | contribs)
Jump to navigation Jump to search

Homepage of the PlantLibra conference

Plantlibra is an EU-funded research project about risks and benefits of plant food supplements.

Plant-based food supplements (PFS) have been and are increasingly used across the European Union, with ingredients often deriving from Third Countries. The knowledge on the safety and benefits of these products – particularly in Europe - is lagging behind the demands of the market and of regulators. Competent authorities, food chain operators and consumers often face difficulties in making informed decisions.

PlantLIBRA aims to foster safe use of food supplements containing or consisting of plants and/or herbal extracts, chiefly by increasing science-based decision-making by regulators and food chain operators, through data, information and tools. PlantLIBRA is structured to develop, validate and disseminate methodologies for risk and benefit assessment, to greatly expand, generate and make available knowledge on PFS, and implement sustainable international cooperation. Through the multi- disciplinary consortium of PlantLIBRA, researchers, excelling in different fields, will share their work and expertise among themselves and with the leading stakeholders towards an integrated "science of botanicals".

  • Acronym: PlantLIBRA
  • Project ID: 245199
  • Call: FP7-KBBE-2009-3
  • Programme: FP7
  • Activity codes: KBBE-2009-2-4-02

Ideas for consumer perception study

Question
What could be asked in the consumer perception study about the benefit-risk assessment?
Rationale
A benefit-risk assessment should be useful for some practical purpose. There are two possible uses: the authority uses it to make decisions about acceptability of health claims or products in the market; and the consumer uses it to make informed purchasing decisions. In this study we could and should test for how the consumer perceives the benefit-risk information depending on a) the outcome (i.e. clear vs unclear benefit) and b) way of expressing the conclusion.
Answer
The following table describes different pieces of user information that are used to inform the user about the net health benefits of a mock-up PFS product.
Different ways of describing benefit-risk information to a consumer.
Different ways of expressing outcomes Different assessment outcomes
Net benefit is high Net benefit is zero
DALY estimates with uncertainties According to a benefit-risk assessment, using this product for a year will bring more health worth 3 healthy days (uncertainty from 0 to 10 days). According to a benefit-risk assessment, using this product for a year will bring more health worth 0.5 healthy days (uncertainty from –5 to 6 days).
Descriptive without uncertainty According to a benefit-risk assessment, using this product will bring a small health benefit. According to a benefit-risk assessment, using this product will bring a negligible health benefit.
Descriptive with uncertainty According to a benefit-risk assessment, using this product will bring a small health benefit (result is uncertain and may be missing). According to a benefit-risk assessment, using this product is as likely to produce a small health benefit as a small health harm.


Datbase fields

Composition data

Bibliographic Reference

Author Title Journal Volume Year Pages Publisher Reference information

Plant Food Supplement

Plant Food Supplement

Food Information

Maturity Country of origin Region Season Morphological description Molecular identification Growing condition EuroFIR classification Generic food name Commercial food name GMO Diseased plant Plant description

Processing

Shape, state or form Heat treatment Cooking method Treatment applied Preservation method

Sampling Information

Sample year Primary sample unit size Primary sample units Analytical sample size Analytical portion size Analytical portions Portion replicates Sample plan Sample handling

Compositional Information

Compound class Analytical std.source Analytical method name Analytical method Minimum level Maximum level Standard deviation Mean standard error Aim of the method Purpose of the method Extraction and preparation Identification Activity Compositional comments

Quality Assessment

Plant/Food description Processing defined Sampling plan Sample handling Compound identification Analytical method Analytical performance Quality code Quality comments

Beneficial data

Bibliographic Reference

Author Title Journal Volume Year Pages Publisher Reference information

Plant Food Supplement

Plant Food Supplement

Food Information

Part Country of origin EuroFIR classification Processed food name Plant remarks

Processing

Shape, state or form Heat treatment Cooking method Treatment applied Preservation method Processing remarks

Test Material

Compound class Source Purity Measured quantity Compound remarks

in vitro

Cell type/line Positive control Negative control

in vivo

Route of administration Species Strain/race Gender General population Study subjects Experimental design Concentration/level Control group Clinical aspects Treatment duration Other treatment

in vitro

Standard assay

in vivo

Experiment duration

in vitro

Study remarks

in vivo

Major parameters Gender specific effect

Results

Result remarks Non-effective level Adverse effects studied Adverse effects, text ADI NOAEL

Quality Assessment

Study design Subject Test material Conduction of study Methodology Results Quality code Quality comments

Overall remarks

Overall remarks

Adverse effect data

Bibliographic Reference

Author Title Journal Volume Year Pages Publisher Reference information

Plant Food Supplement

Additional information Other bioactive compounds

Event history

Administration Gender Subject characterization Description of the event

Adverse effects

Clinical aspects Dose ingested Intake duration Treatment of AE De-challenge / Re-challenge Gender specific effect Conclusion Effective dose Reviewer comments

Quality Assessment

PFS information Intake Patient history Concurrent diseases Concomitant medications Adverse event Herbal preparation Quality code Quality comments

PFS data

Identification

Name Trade name Data completed

Ingredients

Ingredients

Plant Food Supplement

Interactions Legislation Reference information Links

See also

Related files

<mfanonymousfilelist></mfanonymousfilelist>

Retrieved from "https://en.opasnet.org/index.php?title=Plantlibra&oldid=31337"